Cardiac Complications in Patients Infected with COVID-19

1. Centrul Na ional de Supraveghere şi Control al Bolilor Transmisibile https://www.cnscbt.ro/index.php/situatiala-nivel-global-actualizata-zilnicSearch in Google Scholar

2. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA Feb 24. doi: 10.1001/jama.2020.264810.1001/jama.2020.2648Search in Google Scholar

3. Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA 2020 Mar 11. doi: 10.1001/jama.2020.3633.10.1001/jama.2020.3633Search in Google Scholar

4. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x.10.1007/s00134-020-05991-xSearch in Google Scholar

5. Li B, Yang J, Zhao F et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 May;109(5):531-538. doi: 10.1007/s00392-020-01626-910.1007/s00392-020-01626-9Search in Google Scholar

6. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.10.1038/s41569-020-0360-5Search in Google Scholar

7. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3.10.1016/S0140-6736(20)30566-3Search in Google Scholar

8. Ten Broeke R, Mestrom E, Woo L, Kreeftenberg H. Early treatment with intravenous lipid emulsion in a potentially lethal hydroxychloroquine intoxication. Neth J Med. 2016;74(5):210. PMID: 27323674Search in Google Scholar

9. Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res 2020;116(6):1097-1100. doi: 10.1093/cvr/cvaa07810.1093/cvr/cvaa078Search in Google Scholar

10. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; (10229):1054-1062. doi: 10.1016/S0140-3956736(20)30566-310.1016/S0140-6736(20)30566-3Search in Google Scholar

11. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020; 8 (4):e21. doi: 10.1016/S2213-2600(20)30116-8.10.1016/S2213-2600(20)30116-8Search in Google Scholar

12. Vaduganathan M, Vardeny O, Michel T et al. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med 2020; (17):1653-1659. 382 doi: 10.1056/NEJMsr200576010.1056/NEJMsr2005760712145232227760Search in Google Scholar

13. Danser AHJ, Epstein M, Batlle D. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers. Hypertension 2020;75(6):1382-1385. doi: 10.1161/HYPERTENSIONAHA.120.1508210.1161/HYPERTENSIONAHA.120.15082722504632208987Search in Google Scholar

14. Inciardi RM, Lupi L, Zaccone G et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 2020. doi: 10.1001/jamacardio.2020.109610.1001/jamacardio.2020.1096Search in Google Scholar

15. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz 2020; 45 (3):230-232. DOI: 10.1007/s00059-020-04909-z10.1007/s00059-020-04909-zSearch in Google Scholar

16. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol 2020. doi: 10.1001/jamacardio.2020.128610.1001/jamacardio.2020.1286Search in Google Scholar

17. Sarkisian L, Saaby L, Poulsen TS et al. Clinical Characteristics and Outcomes of Patients with Myocardial Infarction, Myocardial Injury, and Nonelevated Troponins. Am J Med 2016;129:446 e5-446 e21. doi: 10.1016/j.amjmed.2015.11.00610.1016/j.amjmed.2015.11.006Search in Google Scholar

18. Thygesen K, Alpert JS, Jaffe AS et al. Fourth Universal Definition of Myocardial Infarction. Journal of the American College of Cardiology. Volume 72, Issue 18, October 2018. doi: 10.1016/j.jacc.2018.08.103810.1016/j.jacc.2018.08.1038Search in Google Scholar

19. Yang X, Yu Y, Xu J et al. Clinical course and outcomes of critically ill patients with SARS-CoV2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8(5):475-481. doi: 10.1016/S2213-2600(20)30079-510.1016/S2213-2600(20)30079-5Search in Google Scholar

20. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020 Mar 10. doi: 10.1016/j.pcad.2020.03.001.10.1016/j.pcad.2020.03.001712739532169400Search in Google Scholar

21. Wood S. TCT the Heat Beat: COVID-19 and the Heart: Insights from the Front Lines. https://www.tctmd.com/news/covid-19-and-heart-insights-front-lines. Accessed March 15, 2020.Search in Google Scholar

22. Kim IC, Kim JY, Kim HA, Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J. 2020. May 14;41(19):1859. doi: 10.1093/eurheartj/ehaa28810.1093/eurheartj/ehaa288718449132282027Search in Google Scholar

23. Fried JA, Ramasubbu K, Bhatt R et al. The Variety of Cardiovascular Presentations of COVID-19. Circulation. 2020 Jun 9;141(23):1930-1936. doi: 10.1161/CIRCULATIONAHA. 120.04716410.1161/CIRCULATIONAHA.120.047164Search in Google Scholar

24. Caforio AL, Pankuweit S, Arbustini E et al. European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d. doi: 10.1093/eurheartj/eht21010.1093/eurheartj/eht21023824828Search in Google Scholar

25. Lakkireddy DR, Chung MK, Gopinathannair R et al. Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Circulation. 2020 Apr 1;S1547-5271(20)30289-7. doi: 10.1016/j.hrthm.2020.03.02810.1016/j.hrthm.2020.03.028711869732247013Search in Google Scholar

26. Chorin E, Dai M, Shulman E, et al. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Nat Med. 2020 Jun;26(6):808-809. doi: 10.1038/s41591-020-0888-210.1038/s41591-020-0888-232488217Search in Google Scholar

27. Baldi E, Sechi GM, Mare C et al. Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy. N Engl J Med. 2020 Apr 29;NEJMc2010418. doi: 10.1056/NEJMc201041810.1056/NEJMc2010418720442832348640Search in Google Scholar

28. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020 16;ehaa190. doi: 10.1093/eurheartj/ehaa190.10.1093/eurheartj/ehaa190718434832176300Search in Google Scholar

29. Bhatraju PK, Ghassemieh BJ, Nichols M et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500.10.1056/NEJMoa2004500714316432227758Search in Google Scholar

30. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020 doi: 10.1016/j.pcad.2020.03.00110.1016/j.pcad.2020.03.001712739532169400Search in Google Scholar

31. Shi S, Qin M, Shen B et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Mar 10. doi: 10.1016/j.pcad.2020.03.001.10.1016/j.pcad.2020.03.001Search in Google Scholar

32. Rotzinger DC, Beigelman-Aubry C, von Garnier C, Qanadli SD. Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography. Thromb Res. 2020;190:58-59. doi:10.1016/j.thromres.2020.04.01110.1016/j.thromres.2020.04.011715136432302782Search in Google Scholar

33. Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J 2020; 41 (19):1858. doi: 10.1093/eurheartj/ehaa254.10.1093/eurheartj/ehaa254718440632227120Search in Google Scholar

34. Guan WJ, Ni ZY, Hu Y et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382(18):1708-1720. doi: 10.1016/j.jinf. 2020.03.04110.1056/NEJMoa2002032Search in Google Scholar

35. Konstantinides SV, Meyer G, Becattini C et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019; (3). doi: 10.1183/13993003.01647-20110.1183/13993003.01647-2019Search in Google Scholar